Higher acutephysiology and chronic health evaluation II scores and comorbid malignancy independently predicted treatment failure.
2
The two groups were similar with respect to age, sex ratio and Simplified AcutePhysiology Score.
3
Those with and without BSI had similar mean Simplified AcutePhysiology Score (SAPS) II and age.
4
In a multivariate analysis, mortality was associated with older age and higher AcutePhysiology and Chronic Health Evaluation II score.
5
Older age, AcutePhysiology and Chronic Health Evaluation II score, and Paco2 before high-frequency oscillation were independently associated with mortality.
6
The NTIS was significantly associated with AcutePhysiology and Chronic Health II scores, mortality, length of stay, and mechanical ventilation.
7
Higher AcutePhysiology and Chronic Health Evaluation II and Modified End Stage Liver Disease scores were also independently predictive of mortality.
8
Simplified AcutePhysiology Score (SAPS) II and AcutePhysiology And Chronic Health Evaluation (APACHE) III scores were also analyzed.
9
From these patients, AcutePhysiology and Chronic Health II scores, ICU mortality, length of stay, mechanical ventilation, and concomitant medication were recorded.
10
Illness severity was assessed using AcutePhysiology and Chronic Health Evaluation IV, Simplified AcutePhysiology Score-3, and Sequential Organ Failure Assessment scores.
11
The patient cohort average AcutePhysiology and Chronic Health Evaluation II score was 22, which was higher than previous intensive insulin clinical studies.
12
This was significantly better than the predictive power of either AcutePhysiology and Chronic Health Evaluation II or new injury severity score scoring systems.
13
Multivariate analysis (logistic regression) was performed separately modeling with AcutePhysiology and Chronic Health Evaluation II and Modified End Stage Liver Disease.
14
Background and objectives: The Score for Neonatal AcutePhysiology II with Perinatal Extension (SNAPPE-II) is a vital tool for prognostication in newborns.
15
Mean values were age, 50.6 years; score on the AcutePhysiology and Chronic Health Evaluation, 60.1; and protocol duration, 3.4 days.
16
We analyzed 406 patients with a median age of 61 years and an AcutePhysiology and Chronic Health Evaluation II of 23.